Pgpipn Increased The Sensitivity Of Human Ovarian Cancer Cells To Ddp

PGPIPN increased the sensitivity of human ovarian cancer cells to DDP ...
PGPIPN increased the sensitivity of human ovarian cancer cells to DDP ...
PGPIPN increased the sensitivity of human ovarian cancer cells to DDP ...
PGPIPN increased the sensitivity of human ovarian cancer cells to DDP ...
PGPIPN increased the sensitivity of human ovarian cancer cells to DDP ...
PGPIPN increased the sensitivity of human ovarian cancer cells to DDP ...
The sensitivity of human ovarian carcinoma cells to WT TP53 ...
The sensitivity of human ovarian carcinoma cells to WT TP53 ...
PGPIPN induced G2/M-phase accumulation of human ovarian cancer cells ...
PGPIPN induced G2/M-phase accumulation of human ovarian cancer cells ...
Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to ...
Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to ...
The responsiveness of primary human epithelial ovarian cancer cells for ...
The responsiveness of primary human epithelial ovarian cancer cells for ...
The culture and identification of human primary ovarian cancer cells ...
The culture and identification of human primary ovarian cancer cells ...
The correlation of HSP27 expression and DDP sensitivity ovarian cancer ...
The correlation of HSP27 expression and DDP sensitivity ovarian cancer ...
Overexpression of DDB2 enhances the sensitivity of human ovarian cancer ...
Overexpression of DDB2 enhances the sensitivity of human ovarian cancer ...
PGPIPN induces human ovarian cancer SKOV 3 cells underwent growth ...
PGPIPN induces human ovarian cancer SKOV 3 cells underwent growth ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Ex vivo CP exposure of primary human ovarian cancer cells induced ...
Ex vivo CP exposure of primary human ovarian cancer cells induced ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Metformin and DDP inhibit the cell viability of ovarian cancer HO-8910 ...
Metformin and DDP inhibit the cell viability of ovarian cancer HO-8910 ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Tβ4–17 peptide enhances the chemo-sensitivity of ovarian cancer cells ...
Overexpression of SLC25A21-AS1 increased the sensitivity of ovarian ...
Overexpression of SLC25A21-AS1 increased the sensitivity of ovarian ...
Overexpression of SLC25A21-AS1 increased the sensitivity of ovarian ...
Overexpression of SLC25A21-AS1 increased the sensitivity of ovarian ...
Cisplatin sensitivity and NER capacity of human ovarian cancer cell ...
Cisplatin sensitivity and NER capacity of human ovarian cancer cell ...
REG3A promotes proliferation and DDP resistance of ovarian cancer cells ...
REG3A promotes proliferation and DDP resistance of ovarian cancer cells ...
(PDF) NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to ...
(PDF) NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to ...
PL selectively inhibited the growth of human ovarian cancer cells. (a ...
PL selectively inhibited the growth of human ovarian cancer cells. (a ...
SC79 attenuated the effect of LaCl3 combined with DDP in ovarian cancer ...
SC79 attenuated the effect of LaCl3 combined with DDP in ovarian cancer ...
Full article: Advancing Ovarian Cancer Therapeutics: The Role of ...
Full article: Advancing Ovarian Cancer Therapeutics: The Role of ...
Knocking down or out EEF1D gene expression increased the sensitivity of ...
Knocking down or out EEF1D gene expression increased the sensitivity of ...
Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of ...
Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of ...
cells from ovarian cancer tissue are hypersensitive to DNA damage. (A ...
cells from ovarian cancer tissue are hypersensitive to DNA damage. (A ...
miR-146b enhanced ovarian cancer cell sensitivity to chemotherapeutic ...
miR-146b enhanced ovarian cancer cell sensitivity to chemotherapeutic ...
Cisplatin-sensitive and -resistant human ovarian cancer cells show ...
Cisplatin-sensitive and -resistant human ovarian cancer cells show ...
LaCl3 promoted cell apoptosis caused by DDP in ovarian cancer cells (n ...
LaCl3 promoted cell apoptosis caused by DDP in ovarian cancer cells (n ...
LaCl3 promoted cell death caused by DDP in ovarian cancer cells (n ...
LaCl3 promoted cell death caused by DDP in ovarian cancer cells (n ...
Novel players in the development of chemoresistance in ovarian cancer ...
Novel players in the development of chemoresistance in ovarian cancer ...
PL synergized with DDP in OVCAR3 ovarian cancer cells. (a) The growth ...
PL synergized with DDP in OVCAR3 ovarian cancer cells. (a) The growth ...
PGPIPN regulated the contents of proteins associated with HSF1/HSP70 ...
PGPIPN regulated the contents of proteins associated with HSF1/HSP70 ...
PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer ...
PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer ...

Loading image details...

Source
Dimensions